STOCK TITAN
  1. Home
  2. PHRBY

PHARMARON BEIJING CO Stock Price, News & Analysis

PHRBY OTC Link

Company Description

PHARMARON BEIJING CO (OTC Link: PHRBY) is a publicly traded testing laboratories company in the Professional, Scientific, and Technical Services sector.

This page provides a comprehensive overview of PHRBY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
352.7M
Shares outstanding

Latest News

View All
—

Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

—

Pharmaron Acquires Commercial API Manufacturing Facility in the United States

acquisition

PHARMARON BEIJING CO has 2 recent news articles. Key topics include acquisition. View all PHRBY news →

SEC Filings

View All

No SEC filings available for PHRBY.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PHRBY Company Profile & Sector Positioning

PHARMARON BEIJING CO (PHRBY) operates in the Testing Laboratories industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC Link.